Format

Send to

Choose Destination
J Thorac Oncol. 2007 Jun;2(6):461-5.

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) pathway signaling.

Author information

1
Department of Pharmacology and University of Colorado Comprehensive Cancer Center, University of Colorado at Denver and Health Sciences Center, Aurora, Colorado 80010, USA. Andrew.Thorburn@uchsc.edu

Abstract

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo1L is a death ligand, a cytokine that activates apoptosis through cell surface death receptors. TRAIL is thought to be important in host tumor surveillance and metastasis suppression, and various therapeutic agonists that activate TRAIL receptors to induce tumor cell apoptosis are in clinical development. This review discusses recent findings about TRAIL pathway signaling and relates the signaling mechanisms to issues that need to be considered as we try to manipulate TRAIL signaling to treat cancer.

PMID:
17545839
DOI:
10.1097/JTO.0b013e31805fea64
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center